scholarly journals Plasma miR-1273g-3p acts as a potential biomarker for early Breast Ductal Cancer diagnosis

2020 ◽  
Vol 92 (1) ◽  
Author(s):  
Huan Guo ◽  
Xiangting Zeng ◽  
Haining Li ◽  
Yanxiang Guo ◽  
Tao Wang ◽  
...  
Keyword(s):  
Cancer Diagnosis ◽  
Ductal Cancer ◽  
Potential Biomarker

Ultra-sensitive MicroRNA-21 detection based on multiple cascaded strand displacement amplification and CRISPR/Cpf1 (MC-SDA/CRISPR/Cpf1)

2021 ◽  
Author(s):  
Xiaolong Chen ◽  
Yuanyi Deng ◽  
Gaihua Cao ◽  
Yifan Xiong ◽  
Danqun Huo ◽  
...  
Keyword(s):  
Cancer Diagnosis ◽  
Analytical Method ◽  
Strand Displacement ◽  
Strand Displacement Amplification ◽  
Diagnosis And Prognosis ◽  
Potential Biomarker ◽  
Cancer Diagnosis And Prognosis

MicroRNA-21 (miR-21) has been considered as a potential biomarker for cancer diagnosis and prognosis due to its highly expressed in tumors. Here, an analytical method which integrates the multiple cascaded...

Long noncoding RNA MALAT1 acts as a potential biomarker in cancer diagnosis and detection: a meta-analysis

2019 ◽  
Vol 13 (1) ◽  
pp. 45-54 ◽  
Author(s):  
Hongbing Mei ◽  
Yuhan Liu ◽  
Qun Zhou ◽  
Kun Hu ◽  
Yuchen Liu
Keyword(s):  
Cancer Diagnosis ◽  
Long Noncoding Rna ◽  
Noncoding Rna ◽  
Meta Analysis ◽  
Potential Biomarker

scholarly journals Identification of Circulating MiR-25 as a Potential Biomarker for Pancreatic Cancer Diagnosis

2016 ◽  
Vol 39 (5) ◽  
pp. 1716-1722 ◽  
Author(s):  
Ting Deng ◽  
Yaozong Yuan ◽  
Chunni Zhang ◽  
Chenyu Zhang ◽  
Weiyan Yao ◽  
...  
Keyword(s):  
Pancreatic Cancer ◽  
Cancer Diagnosis ◽  
Diagnostic Value ◽  
Serum Tumor Marker ◽  
Quantitative Real Time Pcr ◽  
Serum Samples ◽  
Qrt Pcr ◽  
Potential Biomarker ◽  
Potential Use ◽  
Normal Controls

Background: The aim of this study was to identify novel microRNAs for potential use in the diagnosis of pancreatic cancer (PaC). Methods: A total of 1063 serum samples from 303 patients with PaC were collected, and the expression level of miR-25 was measured using quantitative real-time PCR (qRT-PCR). Results: We found that miR-25 had significant diagnostic value for the differential diagnosis of PaC in normal controls with an AUC (the area under the ROC curve) of 0.915 (95% CI: 0.893-0.937) that was significantly higher compared with an AUC of 0.725 for serum tumor marker carcinoembryonic antigen (CEA) and an AUC of 0.844 for CA19-9. Conclusions: These data suggest that serum miR-25 has strong potential as a novel biomarker for the early detection of PaC.

scholarly journals The functions and targets of miR‐212 as a potential biomarker of cancer diagnosis and therapy

2020 ◽  
Vol 24 (4) ◽  
pp. 2392-2401 ◽  
Author(s):  
Wenjun Chen ◽  
Jing Song ◽  
Hongjun Bian ◽  
Xia Yang ◽  
Xiaoyu Xie ◽  
...  
Keyword(s):  
Cancer Diagnosis ◽  
Diagnosis And Therapy ◽  
Potential Biomarker ◽  
Cancer Diagnosis And Therapy

204 Plasma circulating miRNAs: A new potential biomarker for prostate cancer diagnosis

2014 ◽  
Vol 13 (1) ◽  
pp. e204
Author(s):  
S. Giglio ◽  
C. De Nunzio ◽  
R. Cirombella ◽  
A. Tubaro ◽  
A. Vecchione
Keyword(s):  
Prostate Cancer ◽  
Cancer Diagnosis ◽  
Circulating Mirnas ◽  
Prostate Cancer Diagnosis ◽  
Potential Biomarker

scholarly journals Evaluation of serum phosphopeptides as potential biomarkers of gastric cancer

RSC Advances ◽  
2017 ◽  
Vol 7 (35) ◽  
pp. 21630-21637 ◽  
Author(s):  
Guijin Zhai ◽  
Liping Yang ◽  
Qun Luo ◽  
Kui Wu ◽  
Yao Zhao ◽  
...  
Keyword(s):  
Gastric Cancer ◽  
Cancer Diagnosis ◽  
Early Stage ◽  
Potential Biomarker ◽  
Potential Biomarkers

A serum phosphopeptide (DpSGEGDFLAEGGGVR) was demonstrated to be a potential biomarker for gastric cancer diagnosis, particularly for early stage cases.

A panel of seven-miRNA signature in plasma as potential biomarker for colorectal cancer diagnosis

Gene ◽  
2019 ◽  
Vol 687 ◽  
pp. 246-254 ◽  
Author(s):  
Huo Zhang ◽  
Mingxia Zhu ◽  
Xia Shan ◽  
Xin Zhou ◽  
Tongshan Wang ◽  
...  
Keyword(s):  
Colorectal Cancer ◽  
Cancer Diagnosis ◽  
Mirna Signature ◽  
Potential Biomarker

scholarly journals UHRF1: The key regulator of epigenetics and molecular target for cancer therapeutics

Tumor Biology ◽  
2017 ◽  
Vol 39 (2) ◽  
pp. 101042831769220 ◽  
Author(s):  
Harsimran Sidhu ◽  
Neena Capalash
Keyword(s):  
Dna Methylation ◽  
Cancer Cells ◽  
Cancer Diagnosis ◽  
Growth Arrest ◽  
Cancer Therapeutics ◽  
Molecular Target ◽  
Compelling Evidence ◽  
Diagnosis And Prognosis ◽  
Ability To Act ◽  
Potential Biomarker

UHRF1 is a master regulator of epigenome as it coordinates DNA methylation and histone modifications. Compelling evidence suggests a strong link between UHRF1 overexpression and tumorigenesis, substantiating its ability to act as a potential biomarker for cancer diagnosis and prognosis. UHRF1 also mediates repair of damaged DNA that makes cancer cells resistant toward cytocidal drugs. Hence, understanding the molecular mechanism of UHRF1 regulation would help in developing cancer therapeutics. Natural compounds have shown applicability to downregulate UHRF1 leading to growth arrest and apoptosis in cancer cells.

MicroRNA-21 as a Potential Biomarker for Colorectal Cancer Diagnosis: A Meta-analysis

2016 ◽  
Vol 17 (8) ◽  
pp. 1-13
Author(s):  
Chao-Hui Zhen ◽  
Guo-Jun Yao ◽  
Yan Tan ◽  
Lu Yang ◽  
Xiao-Fang Yu ◽  
...  
Keyword(s):  
Colorectal Cancer ◽  
Cancer Diagnosis ◽  
Meta Analysis ◽  
Potential Biomarker
Sign in / Sign up

Export Citation Format

Share Document